Synthesis and evaluation of tacrine-huperzine A hybrids as acetylcholinesterase inhibitors of potential interest for the treatment of Alzheimer's disease

被引:82
作者
Badia, A
Banos, JE
Camps, P
Contreras, J
Gorbig, DM
Munoz-Torrero, D
Simon, M
Vivas, NM
机构
[1] Univ Barcelona, Fac Farm, Quim Farmaceut Lab, E-08028 Barcelona, Spain
[2] Univ Autonoma Barcelona, Fac Med, Dept Farmacol & Terapeut, Barcelona 08913, Spain
关键词
Alzheimer's disease; acetylcholinesterase inhibitors; tacrine-related compounds; huperzine A-related compounds; Friedlander reaction;
D O I
10.1016/S0968-0896(98)00015-7
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Seventeen polycyclic compounds related to tacrine and huperzine A have been prepared as racemic mixtures and tested as acetylcholinesterase (AChE) inhibitors. The conjunctive pharmacomodulation of huperzine A (carbobicyclic substructure) and tacrine (4-aminoquinoline substructure) led to compound 7jy, 2.5 times less active than tacrine as AChE inhibitor, but much more active than its (Z)-stereoisomer (7iy). Derivatives 7dy and 7ey, lacking the ethylidene substituent, showed to be more active than tacrine. Many other structural modifications of 7jy led to less active compounds. Compounds 7dy and 7ey also showed to be much more active than tacrine in reversing the partial neuromuscular blockade induced by d-tubocurarine. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:427 / 440
页数:14
相关论文
共 46 条
[11]   Improved synthesis of methyl 7,7-ethylenedioxy-3-methyl-9-oxobicyclo[3.3.1]non-3-ene-1-carboxylate, intermediate for the synthesis of Huperzine A analogues [J].
Camps, P ;
Contreras, J ;
FontBardia, M ;
Solans, X .
SYNTHETIC COMMUNICATIONS, 1996, 26 (01) :9-18
[12]   Synthesis, conformational analysis and transannular reactions of 5,9-propanobenzo[7]annulene derivatives [J].
Camps, P ;
Gorbig, D ;
MunozTorrero, V ;
Perez, F .
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS, 1997, 62 (10) :1585-1598
[13]   DESIGN AND SYNTHESES OF 4-ACYLAMINOPYRIDINE DERIVATIVES - NOVEL HIGH-AFFINITY CHOLINE UPTAKE ENHANCERS .2. [J].
CHAKI, H ;
YAMABE, H ;
SUGANO, M ;
MORITA, S ;
BESSHO, T ;
TABATA, R ;
SAITO, KI ;
EGAWA, M ;
TOBE, A ;
MORINAKA, Y .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (14) :1495-1500
[14]  
Crich D., 1987, ALDRICHIM ACTA, V20, P35
[15]   Substituted (pyrroloamino)pyridines: Potential agents for the treatment of Alzheimer's disease [J].
Davis, L ;
Olsen, GE ;
Klein, JT ;
Kapples, KJ ;
Huger, FP ;
Smith, CP ;
Petko, WW ;
Cornfeldt, M ;
Effland, RC .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (02) :582-587
[16]  
DELGIUDICE MR, 1996, IL FARMACO, V51, P693
[17]   A NEW AND RAPID COLORIMETRIC DETERMINATION OF ACETYLCHOLINESTERASE ACTIVITY [J].
ELLMAN, GL ;
COURTNEY, KD ;
ANDRES, V ;
FEATHERSTONE, RM .
BIOCHEMICAL PHARMACOLOGY, 1961, 7 (02) :88-&
[18]   SYNTHESIS AND EVALUATION OF 5-AMINO-5,6,7,8-TETRAHYDROQUINOLINONES AS POTENTIAL AGENTS FOR THE TREATMENT OF ALZHEIMERS-DISEASE [J].
FINK, DM ;
BORES, GM ;
EFFLAND, RC ;
HUGER, FP ;
KURYS, BE ;
RUSH, DK ;
SELK, DE .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (18) :3645-3651
[19]   The X-ray structure of a transition state analog complex reveals the molecular origins of the catalytic power and substrate specificity of acetylcholinesterase [J].
Harel, M ;
Quinn, DM ;
Nair, HK ;
Silman, I ;
Sussman, JL .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (10) :2340-2346
[20]  
HE XC, 1993, CHINESE CHEM LETT, V4, P597